Table 3.
Quartiles of riboflavin intake | Ptrend | ||||
---|---|---|---|---|---|
Q1 (n = 840) (< 1.6 mg/d) |
Q2 (n = 841) (1.6–1.82 mg/d) |
Q3 (n = 841) (1.83–2.09 mg/d) |
Q4 (n = 840) (> 2.09 mg/d) |
||
Depression | |||||
Crude | 1 (Ref.) | 0.87 (0.71–1.08) | 0.78 (0.63–0.96) | 0.66 (0.54–0.83) | < 0.001 |
Model 1 | 1 (Ref.) | 0.85 (0.68–1.07) | 0.73 (0.57–0.91) | 0.66 (0.52–0.83) | < 0.001 |
Model 2 | 1 (Ref.) | 0.83 (0.65–1.05) | 0.73 (0.58–0.93) | 0.65 (0.51–0.83) | < 0.001 |
Model 3 | 1 (Ref.) | 0.82 (0.64–1.05) | 0.73 (0.56–0.94) | 0.65 (0.49–0.86) | 0.01 |
Model 4 | 1 (Ref.) | 0.82 (0.63–1.05) | 0.71 (0.55–0.92) | 0.66 (0.49–0.88) | 0.01 |
Anxiety | |||||
Crude | 1 (Ref.) | 0.78 (0.59–1.03) | 0.77 (0.59–1.02) | 0.67 (0.51–0.89) | 0.01 |
Model 1 | 1 (Ref.) | 0.70 (0.52–0.95) | 0.69 (0.51–0.93) | 0.68 (0.51–0.92) | 0.01 |
Model 2 | 1 (Ref.) | 0.67 (0.49–0.92) | 0.73 (0.53–0.99) | 0.67 (0.49–0.93) | 0.03 |
Model 3 | 1 (Ref.) | 0.65 (0.47–0.91) | 0.70 (0.50–0.97) | 0.65 (0.45–0.94) | 0.04 |
Model 4 | 1 (Ref.) | 0.66 (0.47–0.92) | 0.68 (0.48–0.95) | 0.64 (0.44–0.94) | 0.03 |
Psychological distress | |||||
Crude | 1 (Ref.) | 0.94 (0.76–1.18) | 0.79 (0.63–0.99) | 0.69 (0.55–0.87) | 0.01 |
Model 1 | 1 (Ref.) | 0.95 (0.75–1.21) | 0.78 (0.61–0.99) | 0.75 (0.58–0.96) | 0.01 |
Model 2 | 1 (Ref.) | 0.92 (0.71–1.18) | 0.78 (0.61–1.01) | 0.73 (0.56–0.94) | 0.01 |
Model 3 | 1 (Ref.) | 0.87 (0.67–1.13) | 0.73 (0.55–0.95) | 0.66 (0.49–0.89) | 0.01 |
Model 4 | 1 (Ref.) | 0.87 (0.67–1.13) | 0.71 (0.54–0.94) | 0.65 (0.48–0.89) | 0.01 |
Model 1: Adjusted for age, sex and energy intake; Model 2: Further adjustment for physical activity, smoking, marital status, education, household size, house possession, diabetes, use of anti-depressant medications and dietary supplements; Model 3: Additional controlling for dietary intakes of fat, n-3 fatty acids, iron, thiamin; Model 4: Further adjusted for BMI.